老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inozyme Pharma

0.9842
+0.02422.52%
盤後：0.9570-0.0272-2.76%19:17 EDT
成交量：26.03萬
成交額：25.28萬
市值：6,322.52萬
市盈率：-0.61
高：0.9999
開：0.9600
低：0.9398
收：0.9600
資料載入中...
總覽公司新聞公告
2021/05/12

重要事件披露

8-K - Current report
2021/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/07

重要事件披露

8-K - Current report
2021/04/21

重要事件披露

8-K - Current report
2021/03/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/03

重要事件披露

8-K - Current report
2020/08/07

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
更多